🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Germany / NCT05967507
Recruiting Not applicable

Laryngoscopy for Neonatal and Infant Airway Management wIth Supplemental Oxygen at Different Flow Rates (OPTIMISE-2)

NCT05967507 · tracked via the Priya Life Science Germany tracker
Sponsor
Thomas Riva
Phase
Not applicable
Started
2023-12-01
Last updated
2026-05-12

Condition(s) studied

Airway Management

Investigational drug(s) / intervention(s)

Low-flow nasal supplemental oxygen with a conventional nasal cannula during tracheal intubation with the C-MAC video laryngoscopeHigh-flow nasal supplemental oxygen (Fisher & Paykel, Auckland, New Zealand) during tracheal intubation with the C-MAC video laryngoscope

Low-flow nasal supplemental oxygen with a conventional nasal cannula during tracheal intubation with the C-MAC video laryngoscope: 0.2 L/kg/min FiO2 1.0 low-flow nasal supplemental oxygen with a conventional nasal cannula during tracheal intubation with the C-MAC video laryngoscope (Karl Storz, Tuttlingen, Germany) with Miller-blade or Macintosh-blade size No. 0 or No. 1.

High-flow nasal supplemental oxygen (Fisher & Paykel, Auckland, New Zealand) during tracheal intubation with the C-MAC video laryngoscope: 2 L/kg/min FiO2 1.0 high-flow nasal supplemental oxygen (Fisher \& Paykel, Auckland, New Zealand) during tracheal intubation with the C-MAC video laryngoscope (Karl Storz, Tuttlingen, Germany) with Miller-blade or Macintosh-blade size No. 0 or No. 1.

Study summary

This study aims to investigate the optimal oxygen flow rate needed during tracheal intubation with the C-MAC video laryngoscope (Karl Storz, Tuttlingen, Germany) using Miller-blade or Macintosh-blade size No. 0 or No. 1 in the operating room or intensive care unit. The investigators hypothesize that the difference between low-flow and high-flow supplemental oxygen is negligible.

Eligibility

Sex
ALL
Min age
—
Max age
52 Weeks
Healthy volunteers
No
Inclusion Criteria: * Pediatric patients requiring oral or nasal tracheal intubation for elective, semi-elective, or urgent surgical and non-surgical indications. * Neonates and infants up to 52 weeks postconceptual age, with legal guardians providing written informed consent before the intervention Exclusion Criteria: * Prediction of difficult intubation upon physical examination or previous history of difficult intubation, mandating a technique different than direct laryngoscopy to secure the airway; * Congenital heart disease demanding FiO2 \< 1.0 * Cardiopulmonary collapse requiring advanced life support * Intubation for emergency surgical and non-surgical indications.

Primary outcome measure(s)

Trial sites (11)

FacilityCityRegionStatus
Children's Hospital of Philadelphia Philadelphia Pennsylvania Recruiting
Perth Children's Hospital Perth Western Australia Recruiting
Hospital Municipal Infantil Menino Jesus, Servicos Medicos de Anestesia São Paulo São Paulo Recruiting
Dept. Anesthesia, The Hospital for Sick Children Toronto Ontario Recruiting
Dept. Anesthesia, Montreal Children's Hospital, McGill University Health Centre Montreal Canada Recruiting
Department of Cardiac Anesthesiology and Intensive Care Medicine, Charité Universitätsmedizin Berlin Germany Recruiting
IRCCS Istituto Giannina Gaslini Genova Italy Recruiting
Kantonsspital Aarau, KSA Aarau Canton of Aargau Recruiting
Luzerner Kantonsspital Lucerne Canton of Lucerne Recruiting
Inselspital Bern Switzerland Recruiting
CHUV Centre Hospitalier Universitaire Vaudois Lausanne Switzerland Active Not Recruiting

More Thomas Riva trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05967507 on ClinicalTrials.gov ↗ ← All trials in Germany